Could Patrick Mahomes dice up the defenses of yesteryear like Steve Young? Might Myles Garrett have outdone Bruce Smith?
Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback